Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Disorders of Hemostasis

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.

Coagulation

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

Extrinsic and Intrinsic Pathways of Hemostasis

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Inhibition of human FcγRIII prevents platelet destruction in a dual-humanized murine model of FNAIT.

Blood advances·2026

Same author

In-vitro diagnostics of adult immune thrombocytopenia - status quo and new developments.

Clinica chimica acta; international journal of clinical chemistry·2026

Same author

Effects of extended storage of blood samples on the results of platelet function testing: an <i>in vitro</i> stability study.

Scandinavian journal of clinical and laboratory investigation·2026

Same author

Neutrophil-reactive autoantibodies in blood donors: Can we expect TRALI?

Transfusion·2026

Same author

Urine-based point-of-care detection of direct oral anticoagulant activity in acute stroke-accuracy at anti-Xa thresholds relevant for intravenous thrombolysis.

Research and practice in thrombosis and haemostasis·2026

Same author

Infant Immunity after Maternal Nipocalimab in Severe Hemolytic Disease of the Fetus and Newborn.

NEJM evidence·2026

Same journal

Update: Immune Tolerance Induction Practice in Haemophilia.

Hamostaseologie·2026

Same journal

Diagnosis and Management of Immune Platelet Transfusion Refractoriness.

Hamostaseologie·2026

Same journal

Too Common to Ignore: Decoding the Complexity of the FGG p.Ala108Gly Variant in Fibrinogen Disorders.

Hamostaseologie·2026

Same journal

Hamostaseologie·2026

Same journal

Hamostaseologie·2026

Same journal

Hamostaseologie·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 9, 2025

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

Pitfalls in Coagulation Testing.

Ulrich J Sachs^1,2

¹Department of Thrombosis and Haemostasis, Giessen University Hospital, Giessen, Germany.

Hamostaseologie

|February 22, 2023

Summary

This summary is machine-generated.

Coagulation laboratory test results can be impacted by biological, physical, and chemical interferences. Understanding these variables is crucial for accurate diagnostic and therapeutic decisions.

More Related Videos

In Vitro Thrombosis Test for Ventricular Assist Devices

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

Related Experiment Videos

Last Updated: Aug 9, 2025

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

A Microfluidic Flow Chamber Model for Platelet Transfusion and Hemostasis Measures Platelet Deposition and Fibrin Formation in Real-time

Published on: February 14, 2017

In Vitro Thrombosis Test for Ventricular Assist Devices

In Vitro Thrombosis Test for Ventricular Assist Devices

Published on: March 21, 2025

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Leveraging Turbidity and Thromboelastography for Complementary Clot Characterization

Published on: June 4, 2020

Area of Science:

Clinical Chemistry
Hematology
Laboratory Medicine

Background:

Coagulation assays are susceptible to numerous variables that can compromise test accuracy.
Inaccurate results can lead to significant consequences for clinical decision-making, including diagnostic and therapeutic strategies.
Understanding potential interferences is vital for reliable laboratory diagnostics.

Purpose of the Study:

To highlight the impact of various interferences on coagulation laboratory assays.
To educate clinicians and laboratory professionals on common pitfalls in coagulation testing.
To emphasize the importance of recognizing and mitigating pre-analytical and analytical interferences.

Main Methods:

Review of seven instructive cases involving (near) miss events in coagulation testing.
Categorization of interferences into biological, physical, and chemical groups.
Discussion of how specific variables affect coagulation test outcomes.

Main Results:

Biological interferences involve actual impairments of the patient's coagulation system (congenital or acquired).
Physical interferences typically arise during the pre-analytical phase of sample handling.
Chemical interferences are often caused by the presence of drugs, particularly anticoagulants, in the blood sample.
Case studies illustrate the practical implications of these interferences.

Conclusions:

Awareness of biological, physical, and chemical interferences is essential for accurate coagulation testing.
Proper sample handling and knowledge of patient medication are critical to avoid pre-analytical errors.
Addressing these interferences improves the reliability of laboratory results and patient care.